ConductScience.org, home

Gene · 8862

NIH grants1,270

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleAPLN papersNewest fiscal year
P01AG036695Molecular Regulation of Stem Cell Aging12025
P01CA163222Targetable epigenetic and transcriptional mechanisms in melanoma thatshape the microenvironment12025
P01ES028938Woods Hole Center for Oceans and Human Health12025
P01HL154998Mechanisms of Recovery from Viral Pneumonia12025
P20GM103418Kansas IDeA Network of Biomedical Research Excellence 512025
P20GM103424Louisiana Biomedical Research Network12025
P20GM103432Wyoming IDeA Networks for Biomedical Research Excellence Phase 412025
P20GM103475Advancing Competitive Biomedical Research in Puerto Rico12025
P20GM113126Nebraska Center for Integrated Biomolecular Communication (CIBC)12025
P30AG013319San Antonio Nathan Shock Center of Excellence in the Biology of Aging12025
P30AG021342Claude D. Pepper Older Americans Independence Center at Yale12025
P30AG024824Claude D. Pepper Older Americans Independence Center at the University of Michigan (UM Pepper Center)12025
P30AG024832UTMB Claude D. Pepper Older Americans Independence Center12025
P30AG028716Duke Claude D. Pepper Older Americans Independence Center12025
P30AG028740University of Florida Older Americans Independence Center (OAIC)12025
P30AG031679Boston OAIC: A Translational Approach to Function Promoting Therapies12025
P30AG044271San Antonio Claude D. Pepper Older Americans Independence Center12025
P30AG072975Rush Alzheimer's Disease Research Center12025
P30AI110527Tennessee Center for AIDS Research (TN-CFAR)12025
P30AI161943Texas Developmental Center for AIDS Research12025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/8862/grants?page=3